US2009023715A1PendingUtilityA1
Wound Healing
Est. expirySep 20, 2024(expired)· nominal 20-yr term from priority
A61P 9/00A61P 35/00A61P 41/00A61P 3/10A61P 25/00A61P 1/02C09B 5/60A61P 17/16C07D 279/28A61P 17/02A61P 19/08A61P 17/00
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A phenothiazinium compound, compositions and medicaments for use in promoting wound healing and a method for promoting wound healing or cosmetic use by applying or administering a phenothiazinium compound to a wound site or the skin, and optionally exposing the wound site or skin to light.
Claims
exact text as granted — not AI-modified1 - 9 . (canceled)
10 . A method of cosmetic treatment comprising:
a) applying or administering to an area to be treated an effective amount of a composition comprising a compound of Formula (I)
wherein:
R 1 -R 6 each independently is selected from H, optionally substituted C 1-6 -alkyl, F, Cl, Br and I;
A and B each independently is selected from:
wherein:
Q is selected from H and optionally substituted C 1-4 -alkyl;
Z is selected from C(R a ) 2 , O, S, SO 2 and NR a in which R a is selected from H and optionally substituted C 1-4 -alkyl;
R 7 and R 8 each independently is selected from H and optionally substituted C 1-6 -alkyl;
Y is a counteranion; and
p is 1, 2 or 3; and
b) optionally exposing the treated area to light.
11 . The method according to claim 10 , wherein said cosmetic treatment is selected from skin rejuvenation, skin thickening, reduction of scar formation and birth mark removal.
12 . The method according to claim 10 , wherein said cosmetic treatment is skin rejuvenation.
13 . The method according to claim 10 , wherein said cosmetic treatment is skin thickening.
14 . The method according to claim 10 , wherein said cosmetic treatment is reduction of scar formation.
15 . The method according to claim 10 , wherein said cosmetic treatment is birth mark removal.
16 . The method according to claim 10 , wherein said composition further comprises a pharmaceutically acceptable diluent or excipient.
17 . The method according to claim 10 , wherein R 7 and R 8 are independently selected from optionally-substituted C 3-6 alkyl.
18 . The method according to claim 10 , wherein A and B are of formula —NR 7 R 8 .
19 . The method according to claim 10 , wherein Y is a counterion selected from F − , Br − , Cl − , I − , NO 3 − , SCN − , ClO 3 − , ClO 4 − , IO 3 − , BF 4 − , HSO 4 − , H 2 PO 4 − , CH 3 SO 4 − , N 3 , SO 4 2− , HPO 4 2− , PO 4 3− , acetate, lactate, citrate, tartrate, glycolate, glycerate, glutamate, β-hydroxyglutamate, glucouronate, gluconate, malate and aspartate.
20 . The method according to claim 10 , wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6 each represents H, and A and B represent —NR 7 R 8 wherein R 7 and R 8 represent butyl.
21 . A method of cosmetic treatment comprising:
a) applying or administering to an area to be treated an effective amount of a composition comprising a compound of Formula (1)
wherein:
R 1 -R 6 each independently is selected from H, optionally substituted C 1-6 -alkyl, F, Cl, Br and I;
A and B each independently is selected from:
wherein:
Q is selected from H and optionally substituted C 1-4 -alkyl;
Z is selected from C(R a ) 2 , O, S, SO 2 , NR a in which R a is selected from H and optionally substituted C 1-4 -alkyl;
R 7 and R 8 each independently is selected from optionally substituted C 3-6 -alkyl;
Y is a counteranion; and
p is 1, 2 or 3; and
b) optionally exposing the treated area to light.Join the waitlist — get patent alerts
Track US2009023715A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.